Clinical Trials in Orbassano, Turin
3 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Colorectal Neoplasms
Seagen, a wholly owned subsidiary of Pfizer400 enrolled383 locationsNCT05253651
Recruiting
INSIDE: Identification of Genomic Screening Pathways in Cancer Patients With DNA Repair Alterations
Prostate Cancer
Fondazione del Piemonte per l'Oncologia400 enrolled2 locationsNCT06334809
Recruiting
Not Applicable
Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical- Prostatectomy v.s. no3D Intervention
Cancer of Prostate
Fondazione del Piemonte per l'Oncologia120 enrolled2 locationsNCT06318559